Open Access

Long non‑coding RNA RNCR3 promotes glioma progression involving the Akt/GSK‑3β pathway

Retraction in: /10.3892/ol.2023.14055

  • Authors:
    • Bing Zhu
    • Shenyan Zhang
    • Ning Meng
    • He Zhang
    • Shaoji Yuan
    • Jin Zhang
  • View Affiliations

  • Published online on: October 18, 2019     https://doi.org/10.3892/ol.2019.11002
  • Pages: 6315-6322
  • Copyright: © Zhu et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Increasing evidence has confirmed that long non‑coding RNAs (lncRNAs) serve critical roles in the development of a large number of human malignancies, including glioma. Several previously published studies have reported that the lncRNA retinal non‑coding RNA3 (RNCR3; also termed LINC00599) exerts important roles in certain human malignancies; however, the precise biological role and underlying molecular mechanisms of RNCR3 in the development of glioma are yet to be fully elucidated. In the present study, it was revealed that the expression of RNCR3 was increased in glioma tissues compared with in corresponding adjacent normal tissues. Furthermore, increased levels of RNCR3 expression were associated with tumor progression and poor survival rates of patients with glioma. In addition, the U87 and U251 cell lines were selected to investigate the biological function and potential mechanisms of RNCR3 in glioma, and it was observed that RNCR3 knockdown led to an impairment of the proliferative and invasive abilities of cells; furthermore, G1 phase arrest was induced in glioma cells in vitro. Finally, the results of western blot analyses revealed that knockdown of RNCR3 led to a decrease in the expression levels of phosphorylated Akt and glycogen synthase kinase‑3β (GSK‑3β), without any clear effect on the expression levels of total Akt and GSK‑3β. Collectively, these results suggested that RNCR3 is able to regulate cell proliferation, the cell cycle and cell invasion in glioma, potentially via the Akt/GSK‑3β signaling pathway.
View Figures
View References

Related Articles

Journal Cover

December-2019
Volume 18 Issue 6

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Zhu B, Zhang S, Meng N, Zhang H, Yuan S and Zhang J: Long non‑coding RNA RNCR3 promotes glioma progression involving the Akt/GSK‑3β pathway Retraction in /10.3892/ol.2023.14055. Oncol Lett 18: 6315-6322, 2019
APA
Zhu, B., Zhang, S., Meng, N., Zhang, H., Yuan, S., & Zhang, J. (2019). Long non‑coding RNA RNCR3 promotes glioma progression involving the Akt/GSK‑3β pathway Retraction in /10.3892/ol.2023.14055. Oncology Letters, 18, 6315-6322. https://doi.org/10.3892/ol.2019.11002
MLA
Zhu, B., Zhang, S., Meng, N., Zhang, H., Yuan, S., Zhang, J."Long non‑coding RNA RNCR3 promotes glioma progression involving the Akt/GSK‑3β pathway Retraction in /10.3892/ol.2023.14055". Oncology Letters 18.6 (2019): 6315-6322.
Chicago
Zhu, B., Zhang, S., Meng, N., Zhang, H., Yuan, S., Zhang, J."Long non‑coding RNA RNCR3 promotes glioma progression involving the Akt/GSK‑3β pathway Retraction in /10.3892/ol.2023.14055". Oncology Letters 18, no. 6 (2019): 6315-6322. https://doi.org/10.3892/ol.2019.11002